BTC $62,542.36 -1.77%
ETH $1,865.70 -1.16%
BNB $603.13 -1.13%
XRP $1.00 -0.37%
SOL $75.26 -1.13%
TRX $0.3323 -0.55%
DOGE $0.0693 -1.15%
ADA $0.1794 -2.61%
BCH $202.49 -5.24%
LINK $8.82 +0.35%
HYPE $56.07 -2.60%
AAVE $85.72 -2.22%
SUI $0.6768 -1.96%
XLM $0.1597 -0.26%
ZEC $483.27 -1.34%
BTC $62,542.36 -1.77%
ETH $1,865.70 -1.16%
BNB $603.13 -1.13%
XRP $1.00 -0.37%
SOL $75.26 -1.13%
TRX $0.3323 -0.55%
DOGE $0.0693 -1.15%
ADA $0.1794 -2.61%
BCH $202.49 -5.24%
LINK $8.82 +0.35%
HYPE $56.07 -2.60%
AAVE $85.72 -2.22%
SUI $0.6768 -1.96%
XLM $0.1597 -0.26%
ZEC $483.27 -1.34%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.